2 research outputs found
Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens
[EN] The development of RNA-based anti-infectives has gained interest with the successful
application of mRNA-based vaccines. Small RNAs are molecules of RNA of <200 nucleotides in
length that may control the expression of specific genes. Small RNAs include small interference RNAs
(siRNAs), Piwi-interacting RNAs (piRNAs), or microRNAs (miRNAs). Notably, the role of miRNAs
on the post-transcriptional regulation of gene expression has been studied in detail in the context of
cancer and many other genetic diseases. However, it is also becoming apparent that some human
miRNAs possess important antimicrobial roles by silencing host genes essential for the progress
of bacterial or viral infections. Therefore, their potential use as novel antimicrobial therapies has
gained interest during the last decade. The challenges of the transport and delivery of miRNAs
to target cells are important, but recent research with exosomes is overcoming the limitations in
RNA-cellular uptake, avoiding their degradation. Therefore, in this review, we have summarised the
latest developments in the exosomal delivery of miRNA-based therapies, which may soon be another
complementary treatment to pathogen-targeted antibiotics that could help solve the problem caused
by multidrug-resistant bacteriaSIWe thank the Junta de Castilla y León (Spain) for funding our research work on microRNAs, grant number LE044P20. A.M. is supported with a postdoctoral fellowship “Margarita Salas”. M.L. is the recipient of a “Beatriz Galindo” grant (Ref. BEAGAL18/00068 - BGP18/00033
Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens
The development of RNA-based anti-infectives has gained interest with the successful application of mRNA-based vaccines. Small RNAs are molecules of RNA of <200 nucleotides in length that may control the expression of specific genes. Small RNAs include small interference RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), or microRNAs (miRNAs). Notably, the role of miRNAs on the post-transcriptional regulation of gene expression has been studied in detail in the context of cancer and many other genetic diseases. However, it is also becoming apparent that some human miRNAs possess important antimicrobial roles by silencing host genes essential for the progress of bacterial or viral infections. Therefore, their potential use as novel antimicrobial therapies has gained interest during the last decade. The challenges of the transport and delivery of miRNAs to target cells are important, but recent research with exosomes is overcoming the limitations in RNA-cellular uptake, avoiding their degradation. Therefore, in this review, we have summarised the latest developments in the exosomal delivery of miRNA-based therapies, which may soon be another complementary treatment to pathogen-targeted antibiotics that could help solve the problem caused by multidrug-resistant bacteria